GS Research Update — April 29, 2026
Updated Thesis
The Goldman Sachs Group, Inc. operates as a leading global financial services firm specializing in investment banking, securities, investment management, and consumer banking. The company benefits from a high-quality business model characterized by strong brand recognition, deep client relationships, and a history of stable leadership.
The investment grade as of this refresh is D — solid business quality. Medium-tier business, very expensive valuation with 98% downside to $18.16 fair value
Key Metrics at a Glance
- Revenue growth: -45.4% year over year
- Net margin: 16.3%
- Forward P/E: 15.6x
- Fair value upside: -98.0% to our estimate of $18
Current price: $926.55
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. The Goldman Sachs Group, Inc. remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full GS research →](/stocks/GS)